Table 3.
Endpoint = ACA/SCD (56 ACA/SCD: 34 SCD + 22 ACA) | ||||
---|---|---|---|---|
Hazard | 95% Conf Int | |||
Parameter | p-value | Ratio | LCL | UCL |
Syncope | 0.023 | 2.03 | 1.10 | 3.72 |
β-blockers among females* | 0.032 | 0.20 | 0.05 | 0.87 |
β-blockers among males* | 0.308 | 0.51 | 0.14 | 1.88 |
E1784K mutation | 0.001 | 0.09 | 0.02 | 0.37 |
D1790G mutation | 0.049 | 0.30 | 0.09 | 0.99 |
QTc per 10 ms (up to 500 ms) | <0.001 | 1.33 | 1.19 | 1.48 |
Year of birth (after 1955) | <0.001 | 1.06 | 1.03 | 1.09 |
*Test for β-blockers x sex interaction: | ||||
β-blockers for males vs females | 0.353 |